Neuland Laboratories Limited (BSE: 524558)
Health Care · Pharmaceuticals · IN
Rs23,294.80
-0.07% today · +68.0% 1Y
Neuland Laboratories Limited (BSE: 524558) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.12B.
Over the last twelve months the share price has gained 68.0%, trading between 11.50K and 23.90K.
Tweenvest scores Neuland Laboratories Limited across four factors: quality 76/100, value 27/100, growth 82/100, dividend 64/100. Its strongest factor is growth.
524558 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.12B
- Revenue (TTM)
- $250.85M
- P/E
- 60.04
- EPS
- 388.01
- Dividend yield
- 0.15%
- Beta (5Y)
- 0.28
- 52-week high
- Rs23,899.00
- 52-week low
- Rs11,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.83M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.59 | +0.09% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.08 | +0.31% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.27 | -0.18% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.12 | +0.18% |
Figures last refreshed Aug 18, 2026.